Navigation Links
Oncothyreon reports full year and fourth quarter 2008 financial results
Date:3/9/2009

......... 23,388 212 24,416 528 Licensing, royalties and other revenue............ - 80 - 103 --------- --------- --------- --------- 36,024 1,938 39,998 3,798 --------- --------- --------- --------- Expenses Research and development.............. 2,401 2,278 9,318 10,011 Manufacturing............. 10,527 1,396 13,675 2,564 General and administrative........... 2,444 3,567 9,749 11,797 Marketing and business development.............. - 26 - 565 Amortization.............. 105 84 422 246 Investment and other (income) expense......... (177) (19) (291) 376 Change in fair value of warrant liability........ - (242) - (1,421) --------- --------- --------- --------- 15,300 7,090 32,873 24,138 --------- --------- --------- --------- Net income (loss)........... 20,724 (5,152) 7,125 (20,340) Other comprehensive income.................... - 1,253 - 3,243 --------- --------- --------- --------- Comprehensive net income (loss)..................... $ 20,724 $ (3,899) $ 7,125 $(17,097) --------- --------- --------- --------- --------- --------- --------- --------- Income (loss) per share - Basic...................... $ 1.06 $ (0.26) $ 0.37 $ (1.04)
'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
2. Oncothyreon to present at BIO CEO & Investor Conference 2009
3. Oncothyreon reports third quarter 2008 financial results
4. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
5. Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
6. Oncothyreon to present at BIO Investor Forum 2008
7. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
8. Oncothyreon announces prioritization plan for development programs
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
11. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
(Date:1/15/2014)... January 15, 2014 AudioNotch is the ... therapy for the treatment of tinnitus. Patients listen to ... and over a period of weeks to months, their tinnitus ... in two forms: Notched Music and Notched White Noise. Now, ...
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... Alberta Centre for Advanced,MNT (Microsystems and Nanotechnology) Products ... Yallup as Chief Technology Officer. In this new,role ... within ACAMP to,build a world-class capability in Alberta ... technology devices, turning them into market-ready,commercial or industrial ...
... are not risk takers with their health, yet up to ... screenings,- 42 percent are at elevated risk for cardiovascular events, yet 20 percent, ... ... MORRISTOWN, N.J., Sept. 22 A new survey of men and,women age 40 ...
... F. Finn, Jr.,C.P.A. ("Finn"), Assignee of the assets of ... that all oral drug delivery,intellectual property will be sold ... The three presentations were:, 1. BIOROD -- ... Affecting the Bioadhesion Performance of,Spheromer III, 3. Pharmacokinetics ...
Cached Biology Technology:Chief Technology Officer Joins ACAMP 2Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 2Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 3Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 4Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 5Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 6Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers' 7Spherics, Inc. Presented Three Key Technologies (BIOROD(TM), BIOGIT(TM), and SPHEROMER(TM)) at the 35th Annual Meeting of Controlled Release Society 2
(Date:4/17/2014)... 17, 2014The development of stem cell therapies to cure ... characterize stem cell populations based on cell surface markers. ... new marker that is highly expressed in a type ... which they describe in an article in BioResearch ... Liebert, Inc., publishers. The article is available free on ...
(Date:4/17/2014)... Down syndrome - or trisomy 21 - is the ... from a chromosomal abnormality where cells of affected individuals ... the human genome). A study conducted by Stylianos Antonarakis ... and Development at the University of Geneva (UNIGE) Faculty ... on how the extra chromosome 21 upsets the equilibrium ...
(Date:4/17/2014)... Clemson professor Rajendra Singh Thursday as a "Champion ... expand solar deployment in the residential, commercial and ... Professor of Electrical and Computer Engineering and director ... a local hero leading the charge across the ... solar power and driving policy changes at the ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... receive $2.8 million in new grants to study the use ... that is increasingly viewed as a worrisome source of water ... one of the most important and least publicized environmental issues ... of our air, water, and soil and has huge potential ...
... is a perilous place for the endangered manatee. While ... activity also poses a great danger to manatee numbers. ... explains that many manatees die and are seriously injured ... known about how manatees perceive their environment. Whether they ...
... forest for the trees may be causing us to ... Even areas with apparently robust trees and lush canopies ... and development, becoming isolated green islands in a sea ... University of Wisconsin-Madison researchers. A new study is ...
Cached Biology News:UC Davis begins $2.8 million in studies of agricultural nitrogen's impacts 2UC Davis begins $2.8 million in studies of agricultural nitrogen's impacts 3Manatees can probably hear which directions boats approach from 2Isolated forest patches lose species, diversity 2Isolated forest patches lose species, diversity 3
... GELase™ Agarose Gel-Digesting Preparation contains a ... for simple, quantitative recovery of intact DNA ... agarose gels following electrophoresis in TAE, TBE, ... be digested directly in the TAE, TBE, ...
... in-house demand is causing shortages in your laboratory ... can cause unwanted distractions, problems and delays. ... hard work and endeavour! Bring us your idea ... it internationally. We work under ISO 9001 quality ...
... demand is causing shortages in your laboratory ... This can cause unwanted distractions, problems and ... for your hard work and endeavour! Bring ... it up and market it internationally. We ...
... demand is causing shortages in your laboratory or ... cause unwanted distractions, problems and delays. ... work and endeavour! Bring us your idea and ... internationally. We work under ISO 9001 quality assurance ...
Biology Products: